AbbVies Humira
Oct 28, 2022
HUMIRA Biosimilars in the US: The Talk of the Psoriatic Arthritis Treatment Market
Psoriatic arthritis (PsA) is a type of chronic inflammatory arthritis that affects approximately 1 in every 10 people with psoriasis. According to the National Psoriasis Foundation, psoriasis is most common in adults aged 30 to 50. However, psoriatic arthritis can develop at any age, including children. Accordin...
Read More...
Nov 19, 2019
Nordisk ties up with Dicerna; Pfizer’s drug gets FDA nod
Novo Nordisk has announced to enter into a collaboration with Dicerna’s RNAi platform to focus on metabolic and liver-related diseases. The companies will be focusing to advance the treatment landscape of the diseases such as non-alcoholic steatohepatitis (NASH), Type 2 diabetes and obesity. Nordisk will be inv...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
